Alzheimer Disease Type 1 C1863052
An early-onset form linked to specific genetic mutations. It can affect people in their 40s or 50s with memory and thinking problems. Treatment aims to slow progression and manage symptoms.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Progressive memory loss
(neurologic)Language impairment (word-finding difficulty)
(neurologic)Disorientation to time and place
(neurologic)Visual hallucinations
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cholinesterase Inhibitors
Acetylcholinesterase inhibitors such as donepezil, rivastigmine, or galantamine are commonly prescribed to enhance cholinergic neurotransmission and temporarily improve cognitive function and daily living capabilities in Alzheimer disease patients.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Cognitive Stimulation Therapy
Structured group sessions involving reality orientation, reminiscence therapy, and activities designed to stimulate thinking, memory, and social interaction. This non-pharmacological approach has demonstrated benefits for cognition and quality of life.
Additional treatment options
Comprehensive Lifestyle Modification Program
Multi-component intervention including regular aerobic exercise, mentally stimulating activities, social engagement, and stress management techniques. Physical activity promotes neuroplasticity and may slow disease progression.
lifestyleMediterranean Diet Adherence
Emphasizing fruits, vegetables, whole grains, olive oil, and fatty fish while limiting red meat and processed foods. This dietary pattern provides anti-inflammatory and antioxidant benefits that may support brain health.
dietaryRegular Neurological and Functional Monitoring
Scheduled assessments of cognitive function, behavioral symptoms, functional abilities, and disease progression. Regular monitoring allows for timely adjustment of care plans and intervention strategies.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Alzheimer Disease Type 1 C1863052?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011.
Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease. Lancet. 2016.
Sevigny J, Chiao P, Bussière T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2016.
Fan J, Song F, Wang Y. Comparative effectiveness of cognitive interventions for Alzheimer's disease: a systematic review and network meta-analysis. J Clin Psychiatry. 2020.
Medication Comparisons
Compare medications used to treat Alzheimer Disease Type 1 C1863052. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy